$ALKS Alkermes plc. Insider Trading
Get free email notifications about insider trading in Alkermes plc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Alkermes plc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Alkermes plc. for free.
CIK Number: 0001520262
IRS Number: 981007018
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALKS
Company Address: CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 00000
Former name: ANTLER SCIENCE TWO PLC, date of change: 2011-08-04
Former name: Antler Science Two Ltd, date of change: 2011-05-09
Market Capitalization: $8.28B
Prev close: $54.77
Average Daily Volume: 838,787
Days Low: $53.97
Year Low: $27.14
Year High: $60.74
Alkermes plc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | ALKS | Alkermes plc. | Wilson Frank Anders | Director | Option Exercise | A | 0.00 | 7,585 | 0 | 7,585 | |
Jun 16 2021 | ALKS | Alkermes plc. | Wilson Frank Anders | Director | Option Exercise | A | 24.72 | 15,677 | 387,535 | 15,677 | |
Jun 16 2021 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 0.00 | 7,585 | 0 | 7,585 | |
Jun 16 2021 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 24.72 | 15,677 | 387,535 | 15,677 | |
Jun 11 2021 | ALKS | Alkermes plc. | Gaffin David Joseph | SVP, CLO, Alkermes, ... | Option Exercise | M | 16.55 | 13,500 | 223,425 | 14,000 | |
Jun 11 2021 | ALKS | Alkermes plc. | Gaffin David Joseph | SVP, CLO, Alkermes, ... | Sell | S | 25.00 | 13,500 | 337,500 | 74,597 | 88.1 K to 74.6 K (-15.32 %) |
Jun 11 2021 | ALKS | Alkermes plc. | Gaffin David Joseph | SVP, CLO, Alkermes, ... | Buy | M | 16.55 | 13,500 | 223,425 | 88,097 | 74.6 K to 88.1 K (+18.10 %) |
Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 1,250 | 0 | 0 | |
Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 23.50 | 368 | 8,648 | 882 | 1.3 K to 882 (-29.44 %) |
Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
Jun 08 2021 | ALKS | Alkermes plc. | ANSTICE DAVID W | Director | Option Exercise | M | 14.60 | 5,000 | 73,000 | 20,000 | |
Jun 08 2021 | ALKS | Alkermes plc. | ANSTICE DAVID W | Director | Sell | S | 24.00 | 5,000 | 120,000 | 73,081 | 78.1 K to 73.1 K (-6.40 %) |
Jun 08 2021 | ALKS | Alkermes plc. | ANSTICE DAVID W | Director | Buy | M | 14.60 | 5,000 | 73,000 | 78,081 | 73.1 K to 78.1 K (+6.84 %) |
Jun 08 2021 | ALKS | Alkermes plc. | Nichols Christian Todd | SVP, Chief Commerci ... | Option Exercise | M | 0.00 | 3,500 | 0 | 7,000 | |
Jun 08 2021 | ALKS | Alkermes plc. | Nichols Christian Todd | SVP, Chief Commerci ... | Payment of Exercise | F | 23.08 | 1,029 | 23,749 | 7,474 | 8.5 K to 7.5 K (-12.10 %) |